Harringtonine

三尖杉脂碱

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameHarringtonine
Drug Alias NameCepholotoxine哈林通碱Harringtonininie三尖杉酯硷粗榧碱 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulants
TargetsNot applicable
Therapy Area/IndicationsMyelodysplastic SyndromesPolycythemia VeraLeukemia, Myeloid, Acute +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesHainan Hotmed Tianya Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesPolycythemia VeraLeukemia, Myeloid, Acute +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeL01C
Related LinksKEGG